UBS Maintains Cencora(COR.US) With Buy Rating, Raises Target Price to $335
Cencora Is Maintained at Buy by UBS
Cencora Analyst Ratings
UBS Adjusts Price Target on Cencora to $335 From $298, Maintains Buy Rating
Citi Maintains Cencora(COR.US) With Buy Rating, Raises Target Price to $330
TD Cowen Maintains Cencora(COR.US) With Buy Rating, Raises Target Price to $335
TD Cowen Adjusts Price Target on Cencora to $335 From $288, Keeps Buy Rating
Baird Adjusts Price Target on Cencora to $314 From $308, Keeps Outperform Rating
Analysts Conflicted on These Healthcare Names: Cencora (COR) and Johnson & Johnson (JNJ)
Morgan Stanley Maintains Cencora(COR.US) With Hold Rating, Raises Target Price to $288
Morgan Stanley Adjusts Cencora Price Target to $288 From $263, Maintains Equal Weight Rating
BofA Securities Maintains Cencora(COR.US) With Hold Rating
Bank of America Securities Reaffirms Their Hold Rating on Cencora (COR)
Cencora Is Maintained at Neutral by B of A Securities
Cencora Analyst Ratings
Mizuho Securities Maintains Cencora(COR.US) With Buy Rating, Raises Target Price to $305
Research Alert: Cor Gains On Pricing Power, Defensive Qualities - Lowering To Hold On Valuation
Leerink Partners Adjusts Price Target on Cencora to $317 From $301, Maintains Outperform Rating
Deutsche Bank Adjusts Cencora Price Target to $285 From $24
Wells Fargo Maintains Cencora(COR.US) With Hold Rating, Raises Target Price to $274